封面
市場調查報告書
商品編碼
1641804

全球酵母萃取物市場按類型、應用和形式分類 - 機會分析和產業預測(2024-2035 年)

Yeast Extract Market By Type (Yeastolate, Yeast Extracts, Active Dry Yeast), By Application (Pharmaceuticals, Biotechnology), By Form (Liquid, Dry): Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日期: | 出版商: Allied Market Research | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

酵母萃取物市場

酵母萃取物市場 - IMG1

2023 年全球酵母萃取物市場價值為 4.409 億美元,預計到 2035 年將達到 10.383 億美元,2024 年至 2035 年的複合年成長率為 7.5%。

酵母萃取物是從酵母(通常是釀酒酵母)的細胞內容物中獲得的天然成分。酵母細胞經由自溶、酵素處理等過程分解,可溶性成分則濃縮成糊狀、粉末狀或液體形式。該萃取物含有維生素、蛋白質、胺基酸、BETA-聚葡萄糖和核苷酸,具有豐富的營養素。

酵母萃取物酵母萃取物物豐富的營養成分使其成為生物製藥領域生產各種藥物的必需成分。因此,生物製藥領域的擴張是酵母萃取物市場的主要驅動力。此外,由於酵母萃取物可作為天然的增味劑,消費者對潔淨標示產品的傾向限制了食品和飲料中人工香料的添加,從而促進了市場的成長。由於酵母萃取物具有顯著的營養價值,因此作為畜禽、水產飼料的補充劑使用已成為一種顯著趨勢。酵母萃取物可提高飼料轉換率並增強牲畜的免疫力。

然而,大規模生產酵母萃取物是一個昂貴的過程,因為它需要專門的設備和優質的發酵過程原料。這限制了價格敏感產業的酵母萃取物採購,抑制了市場發展。相反,由於酵母萃取物發酵符合廢棄物減少和永續回收方法,因此人們對循環經濟的認知不斷提高有望為市場提供有利可圖的機會。酵母萃取物可透過釀造和烘焙行業的產品線輕鬆獲得,從而促進永續性並減少對環境的影響。根據聯合國的報告,採用循環經濟方式預計到2050年將都市固態廢棄物量從每年45億噸以上減少到20億噸以下。因此,酵母萃取物物的工業化生產可望降低其整體價格,並開闢新的市場通路。

部分回顧

酵母萃取物市場根據類型、應用、形式和地區進行細分。根據類型,市場分為酵母鹽、酵母萃取物和活性酵母。從應用角度來看,可分為製藥業和生技業。此外,製藥部門分為疫苗生產、益生菌、抗生素生產和生物製藥。生物技術部門分為細胞培養基和酵素生產。根據形式,市場分為液態和乾態。依照地區,分析分為北美洲(美國、加拿大、墨西哥)、歐洲(法國、德國、義大利、西班牙、英國、俄羅斯和其他歐洲國家地區)、亞太地區(中國、日本、印度、韓國、澳洲和其他亞太地區)以及拉丁美洲、中東和非洲(巴西、南非、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷和其他拉丁美洲、中東和非洲)。

主要發現

根據類型,活性酵母在 2023 年佔據了市場主導地位。

根據應用,製藥業在 2023 年的市場上佔據顯著地位。

從類型來看,乾貨板塊在2023年成為第一大股東。

按地區分類,預計歐洲將在 2023 年創造最高收益。

相關人員的主要利益

本報告定量分析了市場細分、當前趨勢、估計和趨勢分析、2023 年至 2035 年酵母萃取物市場分析的動態,並確定了主要的酵母萃取物機會。

它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。

波特五力分析強調了買家和供應商的潛力,使相關人員能夠做出利潤驅動的商業決策並加強供應商-買家網路。

詳細分析酵母萃取物市場細分,以確定市場機會。

每個地區的主要國家都根據收益貢獻進行分類。

市場公司的定位有利於基準化分析,並能清楚了解市場公司的當前地位。

報告包括區域和全球酵母萃取物市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

本報告中提供的自訂功能

  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
      • 生物製藥產業的成長
      • 生物技術進步
      • 提高生物加工的產量比率和品質
    • 限制因素
      • 生產成本高
      • 監管障礙
    • 機會
      • 新興市場擴張
      • 個性化醫療的應用

第4章酵母萃取物市場(按類型)

  • 概述
  • 酵母菌
  • 酵母萃取物
  • 活性酵母

第5章酵母萃取物市場(依應用)

  • 概述
  • 藥品
    • 藥用酵母萃取物市場(依亞型分類)
  • 生物技術
    • 生物技術酵母萃取物市場(依亞型分類)

第6章酵母萃取物市場(依形式)

  • 概述
  • 液體
  • 烘乾

第7章酵母萃取物市場(按地區)

  • 概述
  • 北美洲
    • 北美藥用酵母萃取物市場(依亞型)
    • 北美生物技術酵母萃取物市場(依亞型)
    • 美國
    • 美國藥用酵母萃取物市場(依亞型)
    • 美國生物技術酵母萃取物市場(按亞型)
    • 加拿大
    • 加拿大藥用酵母萃取物市場(依亞型)
    • 加拿大生物技術酵母萃取物市場(按亞型)
    • 墨西哥
    • 墨西哥藥用酵母萃取物市場(依亞型)
    • 墨西哥生物技術酵母萃取物市場(按亞型)
  • 歐洲
    • 歐洲藥用酵母萃取物市場(依亞型)
    • 歐洲生物技術酵母萃取物市場(依亞型)
    • 法國
    • 法國藥用酵母萃取物市場依亞型分類
    • 法國生物技術酵母萃取物市場(依亞型)
    • 德國
    • 德國藥用酵母萃取物市場依亞型分類
    • 德國生物技術酵母萃取物市場(依亞型)
    • 義大利
    • 義大利藥用酵母萃取物市場(依亞型)
    • 義大利生物技術酵母萃取物市場(依亞型)
    • 西班牙
    • 西班牙藥用酵母萃取物市場(依亞型)
    • 西班牙生物技術酵母萃取物市場(依亞型)
    • 英國
    • 英國藥用酵母萃取物市場(依亞型)
    • 英國生物技術酵母萃取物市場(按亞型)
    • 俄羅斯
    • 俄羅斯藥用酵母萃取物市場依亞型分類
    • 俄羅斯生物技術酵母酵母萃取物市場(依亞型)
    • 其他
    • 其他歐洲國家藥用酵母萃取物市場(依亞型分類)
    • 其他歐洲國家生物技術酵母萃取物市場(依亞型分類)
  • 亞太地區
    • 亞太地區藥用酵母萃取物市場(依亞型)
    • 亞太生物技術酵母萃取物市場(依亞型)
    • 中國
    • 中國藥用酵母萃取物市場依亞型分類
    • 中國生物技術酵母萃取物市場(依亞型)
    • 日本
    • 日本藥用酵母萃取物市場依亞型分類
    • 日本生物技術酵母萃取物市場(依亞型)
    • 印度
    • 印度藥用酵母萃取物市場(依亞型)
    • 印度生物技術酵母萃取物市場(依亞型)
    • 韓國
    • 韓國藥用酵母萃取物市場(依亞型)
    • 韓國生物技術酵母萃取物市場(依亞型)
    • 澳洲
    • 澳洲藥用酵母萃取物市場(依亞型)
    • 澳洲生物技術酵母酵母萃取物市場(按亞型)
    • 其他
    • 亞太地區其他地區藥用酵母萃取物市場(依亞型分類)
    • 亞太地區其他生物技術酵母萃取物市場(依亞型分類)
  • 拉丁美洲、中東和非洲 (LAMEA)
    • LAMEA醫藥酵母萃取物市場(依亞型)
    • LAMEA生物技術酵母萃取物市場(依亞型)
    • 巴西
    • 巴西藥用酵母萃取物市場(依亞型)
    • 巴西生物技術酵母萃取物市場(依亞型)
    • 南非
    • 南非藥用酵母萃取物市場(依亞型分類)
    • 南非生物技術酵母萃取物市場(依亞型)
    • 沙烏地阿拉伯
    • 沙烏地阿拉伯藥用酵母萃取物市場(依亞型)
    • 沙烏地阿拉伯生物技術酵母萃取物市場(按亞型)
    • 阿拉伯聯合大公國(UAE)
    • 阿拉伯聯合大公國醫藥酵母萃取物市場(依亞型)
    • 阿拉伯聯合大公國生物技術酵母萃取物市場(依亞型)
    • 阿根廷
    • 阿根廷藥用酵母萃取物市場(依亞型)
    • 阿根廷生物技術酵母萃取物市場(依亞型)
    • 其他LAMEA
    • 其他LAMEA醫藥酵母萃取物市場(按子類型分類)
    • 其他LAMEA生物技術酵母萃取物市場(按亞型)

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10主要企業的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 主要企業定位(2023年)

第9章 公司簡介

  • LESAFFRE GROUP
  • Kerry Group
  • Lallemand Inc.
  • AngelYeast Co., Ltd.
  • Associated British Foods PLC
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC.
  • Merck KGaA
  • CELLSECO LTD.
  • FUJIFILM Irvine Scientific
  • Nu-Tek BioSciences
簡介目錄
Product Code: A06568

Yeast Extract Market

Yeast Extract Market - IMG1

The global yeast extract market was valued at $440.9 million in 2023 and is projected to reach $1,038.3 million by 2035, registering a CAGR of 7.5% from 2024 to 2035.

Yeast extract is a natural component derived from the cellular content of yeasts, generally Saccharomyces cerevisiae. The yeast cells are broken down through processes such as autolysis or enzymatic treatment and their soluble components are concentrated into a paste, powder, or liquid form. The extract exhibits a rich nutritional profile as it comprises vitamins, proteins, amino acids, beta-glucans, and nucleotides.

The rich nutritional profile of yeast extract has made it a critical ingredient in the biopharmaceutical sector for the production of different medications. Therefore, the expansion of the biopharmaceutical sector is a significant driver of the yeast extract market. In addition, the inclination of consumers toward clean-label products is augmenting the market growth as yeast extract serves as a natural flavor enhancer, thus limiting the addition of artificial flavors in food & beverages. Due to its remarkable nutritional value, the usage of yeast extract as a supplement in the feed of livestock, poultry, and aquatic organisms has become a prominent trend. The extract helps to improve the feed conversion ratios of animals and enhances their immunity.

However, large-scale production of yeast extract is an expensive process as it requires specialized equipment for fermentation processes and good quality raw materials. This limits the purchase of the extract in price-sensitive sectors, hence restraining the market development. On the contrary, rise in awareness regarding circular economy is projected to present lucrative opportunities for the market as the fermentation of yeast extract aligns with the waste reduction and sustainable development approaches. Yeast extract is easily attainable from the byproducts of the brewing or baking industry, hence promoting sustainability and reducing environmental impact. According to a report by the United Nations, the adoption of circular economy approach is anticipated to reduce the volume of municipal solid waste from more than 4.5 billion tons a year to less than 2 billion tons by 2050. Therefore, the production of yeast extract by industrial byproducts is projected to reduce its overall prices and open new avenues for the market.

Segment Review

The yeast extract market is segmented into type, application, form, and region. By type, the market is divided into yeastolate, yeast extracts, and active dry yeast. According to application, it is bifurcated into pharmaceuticals and biotechnology. Further, the pharmaceuticals segment is divided into vaccine production, probiotics, antibiotic production, and biopharmaceuticals. The biotechnology segment is segregated into cell culture media and enzyme production. As per form, the market is classified into liquid and dry. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (France, Germany, Italy, Spain, UK, Russia, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, and rest of LAMEA).

Key Findings

By type, the active dry yeast segment dominated the market in 2023.

According to application, the pharmaceuticals segment acquired a notable stake in the market in 2023.

As per form, the dry segment was the highest shareholder in 2023.

Region wise, Europe was the highest revenue generator in 2023.

Competition Analysis

The major players in the yeast extract market include AngelYeast Co., Ltd., Associated British Foods PLC, CELLSECO LTD., FUJIFILM Irvine Scientific, Kerry Group, Lallemand Inc., LESAFFRE GROUP, Merck KGaA, Nu-Tek BioSciences, Thermo Fisher Scientific Inc., and VWR International, LLC. These major players have adopted various key development strategies such as acquisition, agreement, collaboration, joint venture, partnership, and product launch to strengthen their foothold in the competitive market.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the yeast extract market analysis from 2023 to 2035 to identify the prevailing yeast extract market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the yeast extract market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global yeast extract market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Form

  • Liquid
  • Dry

By Type

  • Yeastolate
  • Yeast Extracts
  • Active Dry Yeast

By Application

  • Pharmaceuticals
    • Sub-type
    • Vaccine Production
    • Probiotics
    • Antibiotic Production
    • Biopharmaceuticals
  • Biotechnology
    • Sub-type
    • Cell Culture Media
    • Enzyme Production

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • UAE
    • Argentina
    • Rest of LAMEA

Key Market Players:

    • LESAFFRE GROUP
    • Lallemand Inc.
    • Associated British Foods PLC
    • CELLSECO LTD.
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Nu-Tek BioSciences
    • Kerry Group
    • VWR International, LLC.
    • FUJIFILM Irvine Scientific
    • AngelYeast Co., Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing Biopharmaceutical Industry
      • 3.4.1.2. Advancements in Biotechnology
      • 3.4.1.3. Improved Yield and Quality in Bioprocessing
    • 3.4.2. Restraints
      • 3.4.2.1. High Production Cost
      • 3.4.2.2. Regulatory Hurdles
    • 3.4.3. Opportunities
      • 3.4.3.1. Expansion in Emerging Markets
      • 3.4.3.2. Application in Personalized Medicine

CHAPTER 4: YEAST EXTRACT MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Yeastolate
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Yeast Extracts
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Active Dry Yeast
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: YEAST EXTRACT MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Pharmaceuticals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Pharmaceuticals Yeast Extract Market by Sub-type
      • 5.2.4.1. Vaccine Production Market size and forecast, by region
      • 5.2.4.2. Vaccine Production Market size and forecast, by country
      • 5.2.4.3. Probiotics Market size and forecast, by region
      • 5.2.4.4. Probiotics Market size and forecast, by country
      • 5.2.4.5. Antibiotic Production Market size and forecast, by region
      • 5.2.4.6. Antibiotic Production Market size and forecast, by country
      • 5.2.4.7. Biopharmaceuticals Market size and forecast, by region
      • 5.2.4.8. Biopharmaceuticals Market size and forecast, by country
  • 5.3. Biotechnology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Biotechnology Yeast Extract Market by Sub-type
      • 5.3.4.1. Cell Culture Media Market size and forecast, by region
      • 5.3.4.2. Cell Culture Media Market size and forecast, by country
      • 5.3.4.3. Enzyme Production Market size and forecast, by region
      • 5.3.4.4. Enzyme Production Market size and forecast, by country

CHAPTER 6: YEAST EXTRACT MARKET, BY FORM

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Liquid
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Dry
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: YEAST EXTRACT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
      • 7.2.3.1. North America Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.3.2. North America Biotechnology Yeast Extract Market by Sub-type
    • 7.2.4. Market size and forecast, by Form
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.2.1. U.S. Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.1.2.2. U.S. Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.1.3. Market size and forecast, by Form
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.2.1. Canada Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.2.2.2. Canada Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.2.3. Market size and forecast, by Form
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.2.1. Mexico Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.3.2.2. Mexico Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.3.3. Market size and forecast, by Form
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
      • 7.3.3.1. Europe Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.3.2. Europe Biotechnology Yeast Extract Market by Sub-type
    • 7.3.4. Market size and forecast, by Form
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. France
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.2.1. France Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.1.2.2. France Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.1.3. Market size and forecast, by Form
      • 7.3.5.2. Germany
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.2.1. Germany Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.2.2.2. Germany Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.2.3. Market size and forecast, by Form
      • 7.3.5.3. Italy
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.2.1. Italy Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.3.2.2. Italy Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.3.3. Market size and forecast, by Form
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.2.1. Spain Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.4.2.2. Spain Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.4.3. Market size and forecast, by Form
      • 7.3.5.5. UK
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.2.1. UK Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.5.2.2. UK Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.5.3. Market size and forecast, by Form
      • 7.3.5.6. Russia
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.2.1. Russia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.6.2.2. Russia Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.6.3. Market size and forecast, by Form
      • 7.3.5.7. Rest of Europe
      • 7.3.5.7.1. Market size and forecast, by Type
      • 7.3.5.7.2. Market size and forecast, by Application
      • 7.3.5.7.2.1. Rest of Europe Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.7.2.2. Rest of Europe Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.7.3. Market size and forecast, by Form
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
      • 7.4.3.1. Asia-Pacific Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.3.2. Asia-Pacific Biotechnology Yeast Extract Market by Sub-type
    • 7.4.4. Market size and forecast, by Form
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.2.1. China Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.1.2.2. China Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.1.3. Market size and forecast, by Form
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.2.1. Japan Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.2.2.2. Japan Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.2.3. Market size and forecast, by Form
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.2.1. India Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.3.2.2. India Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.3.3. Market size and forecast, by Form
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.2.1. South Korea Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.4.2.2. South Korea Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.4.3. Market size and forecast, by Form
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.2.1. Australia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.5.2.2. Australia Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.5.3. Market size and forecast, by Form
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.2.1. Rest of Asia-Pacific Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.6.2.2. Rest of Asia-Pacific Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.6.3. Market size and forecast, by Form
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
      • 7.5.3.1. LAMEA Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.3.2. LAMEA Biotechnology Yeast Extract Market by Sub-type
    • 7.5.4. Market size and forecast, by Form
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.2.1. Brazil Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.1.2.2. Brazil Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.1.3. Market size and forecast, by Form
      • 7.5.5.2. South Africa,
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.2.1. South Africa, Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.2.2.2. South Africa, Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.2.3. Market size and forecast, by Form
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.2.1. Saudi Arabia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.3.2.2. Saudi Arabia Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.3.3. Market size and forecast, by Form
      • 7.5.5.4. UAE
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.2.1. UAE Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.4.2.2. UAE Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.4.3. Market size and forecast, by Form
      • 7.5.5.5. Argentina
      • 7.5.5.5.1. Market size and forecast, by Type
      • 7.5.5.5.2. Market size and forecast, by Application
      • 7.5.5.5.2.1. Argentina Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.5.2.2. Argentina Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.5.3. Market size and forecast, by Form
      • 7.5.5.6. Rest of LAMEA
      • 7.5.5.6.1. Market size and forecast, by Type
      • 7.5.5.6.2. Market size and forecast, by Application
      • 7.5.5.6.2.1. Rest of LAMEA Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.6.2.2. Rest of LAMEA Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.6.3. Market size and forecast, by Form

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. LESAFFRE GROUP
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Key strategic moves and developments
  • 9.2. Kerry Group
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Lallemand Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. AngelYeast Co., Ltd.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Key strategic moves and developments
  • 9.5. Associated British Foods PLC
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. VWR International, LLC.
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Merck KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. CELLSECO LTD.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. FUJIFILM Irvine Scientific
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
  • 9.11. Nu-Tek BioSciences
    • 9.11.1. Company overview
    • 9.11.2. Key executives
    • 9.11.3. Company snapshot
    • 9.11.4. Operating business segments
    • 9.11.5. Product portfolio